[HTML][HTML] Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells
B Stangeland, AA Mughal, Z Grieg, CJ Sandberg… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Oncotarget, 2015•ncbi.nlm.nih.gov
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is
thought that GBM stem cells (GSCs) are critically important in resistance to therapy.
Therefore, there is a strong rationale to target these cells in order to develop new molecular
therapies.
thought that GBM stem cells (GSCs) are critically important in resistance to therapy.
Therefore, there is a strong rationale to target these cells in order to develop new molecular
therapies.
Abstract
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought that GBM stem cells (GSCs) are critically important in resistance to therapy. Therefore, there is a strong rationale to target these cells in order to develop new molecular therapies.
ncbi.nlm.nih.gov